Literature DB >> 8471433

Prognostic significance of cathepsin-D in patients with breast cancer.

J H Winstanley1, S J Leinster, T G Cooke, B R Westley, A M Platt-Higgins, P S Rudland.   

Abstract

The expression of the protease cathepsin-D has been evaluated using an immunohistochemical technique with a polyclonal antibody in paraffin-embedded tissue from 359 patients treated between the years 1975-1981 for Stage I and II breast cancer. One hundred and twenty seven patients (35%) have strongly positive, granular staining, 138 (38%) are intermediately stained in the cytoplasm, and in 94 (26%) no staining is observed. There is a strong positive association between expression of cathepsin-D and the presence of tumour in axillary lymph nodes (P < 0.006). Expression of the protease is associated with significantly poorer survival of patients in univariate analysis (P = 0.025); however, this is not independent of other tumour variables.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471433      PMCID: PMC1968341          DOI: 10.1038/bjc.1993.139

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  The unmasking of antigens in paraffin sections of tissue by trypsin.

Authors:  R C Curran; J Gregory
Journal:  Experientia       Date:  1977-10-15

2.  The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease.

Authors:  M Morisset; F Capony; H Rochefort
Journal:  Biochem Biophys Res Commun       Date:  1986-07-16       Impact factor: 3.575

3.  Estradiol induced proteins in the MCF7 human breast cancer cell line.

Authors:  B Westley; H Rochefort
Journal:  Biochem Biophys Res Commun       Date:  1979-09-27       Impact factor: 3.575

Review 4.  Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?

Authors:  H Rochefort; F Capony; M Garcia; V Cavaillès; G Freiss; M Chambon; M Morisset; F Vignon
Journal:  J Cell Biochem       Date:  1987-09       Impact factor: 4.429

5.  Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.

Authors:  J P Brouillet; C Theillet; T Maudelonde; A Defrenne; J Simony-Lafontaine; J Sertour; H Pujol; P Jeanteur; H Rochefort
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

6.  Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.

Authors:  B R Westley; F E May
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

7.  Two-step affinity-chromatographic purification of cathepsin D from pig myometrium with high yield.

Authors:  E G Afting; M L Recker
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

8.  The curability of breast cancer.

Authors:  D Brinkley; J L Haybrittle
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

9.  The long term prognostic significance of c-erbB-2 in primary breast cancer.

Authors:  J Winstanley; T Cooke; G D Murray; A Platt-Higgins; W D George; S Holt; M Myskov; A Spedding; B R Barraclough; P S Rudland
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

10.  The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.

Authors:  J Winstanley; T Cooke; W D George; G Murray; S Holt; R Croton; K Griffiths; R Nicholson
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more
  16 in total

1.  Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

Authors:  C Charpin; S Garcia; C Bouvier; F Martini; M Lavaut; C Allasia; P Bonnier; L Andrac
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

2.  Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study.

Authors:  R Holm; G Tanum
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

3.  Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.

Authors:  Philip S Rudland; Angela M Platt-Higgins; Lowri M Davies; Suzete de Silva Rudland; James B Wilson; Abdulaziz Aladwani; John H R Winstanley; Dong L Barraclough; Roger Barraclough; Christopher R West; Nigel J Jones
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

4.  Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.

Authors:  R Holm; J Høie; O Kaalhus; J M Nesland
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

Authors:  U J Göhring; A Scharl; U Thelen; A Ahr; G Crombach; B R Titius
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

6.  The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.

Authors:  Dong L Barraclough; Angela Platt-Higgins; Suzete de Silva Rudland; Roger Barraclough; John Winstanley; Christopher R West; Philip S Rudland
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

7.  Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer.

Authors:  L Nakopoulou; A C Lazaris; D Baltas; I Giannopoulou; N Kavantzas; A Tzonou
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.

Authors:  P Athanassiadou; V Sakellariou; E Petrakakou; P Athanassiades; C Zerva; A Liossi; S Michalas
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

9.  Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.

Authors:  A E O'Donoghue; D N Poller; J A Bell; M H Galea; C W Elston; R W Blamey; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

Authors:  E Niskanen; C Blomqvist; K Franssila; P Hietanen; V M Wasenius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.